The London Medicines’ Evaluation Network (LMEN) facilitates information sharing between decision making groups for medicines in London. In particular, the network makes members aware of those medicines that are being considered by decision making groups across London and the outcomes of such considerations. The network also makes members aware of medicines identified through horizon scanning but not yet marketed, and for which consideration by decision making groups may be necessary in the future. In addition, the network seeks to enable sharing of reviews of new medicines; it provides a common template for use by individuals and organisations, as well as a number of published reviews where a London-wide need for such has been identified.
Next meetingNo meetings scheduled
Regional Medicines Information Manager, London Medicines Information Service